| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 51.9784 | 54 |
| GSM780708 | Untreated after 4 days (C2_1) | 42.4198 | 15 |
| GSM780709 | Untreated after 4 days (C3_1) | 52.9397 | 56 |
| GSM780719 | Untreated after 4 days (C1_2) | 54.5293 | 59 |
| GSM780720 | Untreated after 4 days (C2_2) | 54.3014 | 58 |
| GSM780721 | Untreated after 4 days (C3_2) | 53.2125 | 57 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 152.091 | 81 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 122.409 | 78 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 173.209 | 82 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 137.571 | 79 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 115.327 | 77 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 172.66 | 82 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 88.7721 | 73 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 78.0515 | 71 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 156.995 | 81 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 83.5198 | 72 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 72.0687 | 70 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 143.775 | 80 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 50.2999 | 49 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 65.4732 | 67 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 74.1312 | 70 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 51.214 | 52 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 83.3596 | 72 |